Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception (2020)
- Authors:
- Autor USP: ZANGROSSI JUNIOR, HELIO - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.pbb.2020.172938
- Subjects: ANALGÉSICOS; ÓPIO; MEDO; ÁCIDOS ARAQUIDÔNICOS; COMPORTAMENTO ANIMAL; ENCEFALINAS; CANABINOIDES; ANTAGONISTAS; SOMATOSTATINA
- Keywords: Antinociception; Endocannabionoid; Fear; Freezing; Opioid; Periaqueductal gray
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2020
- Source:
- Título: Pharmacology Biochemistry and Behavior
- ISSN: 0091-3057
- Volume/Número/Paginação/Ano: v. 194, art. 172938, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: unspecified-oa
-
ABNT
GODOI, Manuella Machado et al. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception. Pharmacology Biochemistry and Behavior, v. 194, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2020.172938. Acesso em: 08 jan. 2026. -
APA
Godoi, M. M., Zangrossi Junior, H., Cunha, J. M. da, & Zanoveli, J. M. (2020). Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception. Pharmacology Biochemistry and Behavior, 194. doi:10.1016/j.pbb.2020.172938 -
NLM
Godoi MM, Zangrossi Junior H, Cunha JM da, Zanoveli JM. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception [Internet]. Pharmacology Biochemistry and Behavior. 2020 ; 194[citado 2026 jan. 08 ] Available from: https://doi.org/10.1016/j.pbb.2020.172938 -
Vancouver
Godoi MM, Zangrossi Junior H, Cunha JM da, Zanoveli JM. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception [Internet]. Pharmacology Biochemistry and Behavior. 2020 ; 194[citado 2026 jan. 08 ] Available from: https://doi.org/10.1016/j.pbb.2020.172938 - Heterogeneidade da ansiedade experimental no rato: uma analise comportamental e farmacologica
- Reunião anual da federação de sociedades de biologia experimental-FeSBE, 19: Módula temático: serotonina e distúrbios de ansiedade
- Sensitization of 5-HT1A and 5-HT2receptors in the dorsal periaqueductal gray after long-term treatment with imipramine: Evidence from the elevated T-maze test of anxiety
- Serotonin actions within the prelimbic cortex induce anxiolysis mediated by serotonin 1a receptors
- GABA/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze
- Facilitation of panic-related defensive behaviors after corticotrophin-releasing factor (CRF) injection in the rat dorsolateral periaqueductal gray
- Facilitation of '5-HT IND.2A/2C'-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze
- Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: the role of GABA
- Effects of fluoxetine and buspirone on the panicolytic-like response induced by activation of '5-HT IND. 1A' and '5-HT IND. 2A' receptors in the rat dorsal periaqueductal gray
- Role of GABA/benzodiazepine receptors of the dorsal periaqueductal grey and medial hypothalamus of rats in innate and conditioned anxiety responses
Informações sobre o DOI: 10.1016/j.pbb.2020.172938 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003035530.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
